Get the Stockscreener App
3.49
12.94%
+0.40
After Hours:
3.38
-0.11
-3.15%
Lexaria Bioscience Corp Stock (LEXX) Forecast
The Lexaria Bioscience Corp (LEXX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.2734, representing a +22.45% increase from the current price of $3.49. The highest analyst price target is $4.7508, and the lowest is $3.7961.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LEXX Price Target
Average 5.2053
(+49.15% Upside)
Is Lexaria Bioscience Corp (LEXX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.58 | Neutral |
| STOCH(9,6) | 61.87 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.098 | Buy |
| ADX(14) | 18.91 | Neutral |
| William %R | -10.38 | Sell |
| CCI(14) | 294.93 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4735
Buy
|
2.67
Buy
|
| MA20 |
2.5298
Buy
|
2.6952
Buy
|
| MA50 |
3.1647
Buy
|
2.7745
Buy
|
| MA100 |
2.3764
Buy
|
2.4919
Buy
|
| MA200 |
1.7353
Buy
|
2.1912
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, LEXX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on LEXX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.58 indicates that LEXX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 61.87 indicates that LEXX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that LEXX is oversold. This suggests that LEXX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.91 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 294.93 indicates that LEXX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term LEXX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lexaria Bioscience Corp financial reports and earnings history, Lexaria Bioscience Corp (LEXX) stock could reach $1.7143 by 2030, $5.4704 by 2040 and $8.8393 by 2050. See the projected annual prices until 2050 of the Lexaria Bioscience Corp stock below:
- Lexaria Bioscience Corp (LEXX) is expected to reach an average price of $4.9733 in 2035, with a high prediction of $4.7596 and a low estimate of $4.6322. This indicates an $42.50% rise from the last recorded price of $3.49.
- Lexaria Bioscience Corp (LEXX) stock is projected to chart a bullish course in 2040, with an average price target of $5.2052, representing an $49.14% surge from its current level. The forecast ranges from a conservative $5.2277 to a sky-high $5.4704.
- Our analysts predict Lexaria Bioscience Corp (LEXX) to jump 239.77% by 2045, soaring from $11.68 to an average price of $11.86, potentially reaching $11.52. While $11.68 is the low estimate, the potential upside is significant.
- Lexaria Bioscience Corp (LEXX) stock is expected to climb by 2050, reaching an average of $8.3542, a $139.38% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.8393 and $8.3942, respectively, highlighting the market's uncertainty.
Lexaria Bioscience Corp Stock (LEXX) Year by Year Forecast
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2024
Our forecast for LEXX stock price in 2024 now indicates an average price target of $5.6028 with a high forecast of $9.9039 and a low forecast of $1.3016. The average prediction reflects an increase of +60.54% from the last recorded price of $3.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $4.6108 | $3.7961 | $4.7508 | +32.11% |
| July, 2024 | $2.9487 | $2.8598 | $9.9039 | -15.51% |
| August, 2024 | $3.7849 | $2.7402 | $3.9818 | +8.45% |
| September, 2024 | $3.938 | $3.4381 | $4.7096 | +12.84% |
| October, 2024 | $3.7691 | $3.6391 | $4.7159 | +8.00% |
| November, 2024 | $2.9753 | $2.7353 | $4.3322 | -14.75% |
| December, 2024 | $1.8832 | $1.7652 | $3.78 | -46.04% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2025
Lexaria Bioscience Corp Stock (LEXX) is expected to reach an average price of $1.3935 in 2025, with a high prediction of $2.743 and a low estimate of $0.044. This indicates an -60.07% fall from the last recorded price of $3.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.2595 | $1.4837 | $2.6795 | -35.26% |
| February, 2025 | $1.3707 | $1.3257 | $2.4842 | -60.72% |
| March, 2025 | $1.1936 | $0.882 | $1.7327 | -65.80% |
| April, 2025 | $1.1899 | $0.5067 | $1.4445 | -65.91% |
| May, 2025 | $0.7161 | $0.6262 | $2.743 | -79.48% |
| June, 2025 | $0.044 | $0.044 | $0.9762 | -98.74% |
| July, 2025 | $1.3303 | $0.0444 | $1.3303 | -61.88% |
| August, 2025 | $0.9465 | $0.765 | $1.5418 | -72.88% |
| September, 2025 | $0.9144 | $0.7097 | $1.7444 | -73.80% |
| October, 2025 | $1.3607 | $0.866 | $1.4407 | -61.01% |
| November, 2025 | $0.4469 | $0.4165 | $1.4172 | -87.19% |
| December, 2025 | $0.4683 | $0.0485 | $0.7316 | -86.58% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2026
The predicted value for Lexaria Bioscience Corp (LEXX) in 2026 is set at an average of $1.1272. Estimates vary from a peak of $2.133 to a trough of $0.1215, indicating an -67.70% surge from the present price of $3.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3011 | $0.4064 | $1.3011 | -62.72% |
| February, 2026 | $0.8373 | $0.6574 | $1.4726 | -76.01% |
| March, 2026 | $1.3852 | $0.6489 | $1.4735 | -60.31% |
| April, 2026 | $1.5312 | $1.1599 | $1.7568 | -56.13% |
| May, 2026 | $1.4777 | $1.2877 | $2.133 | -57.66% |
| June, 2026 | $0.7756 | $0.7756 | $1.6393 | -77.78% |
| July, 2026 | $0.6041 | $0.1597 | $0.9187 | -82.69% |
| August, 2026 | $0.5563 | $0.5703 | $0.5235 | -84.06% |
| September, 2026 | $0.494 | $0.5489 | $0.5287 | -85.84% |
| October, 2026 | $0.3742 | $0.3967 | $0.3625 | -89.28% |
| November, 2026 | $0.10 | $0.1215 | $0.2462 | -97.14% |
| December, 2026 | $0.1711 | $0.1383 | $0.1337 | -95.10% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lexaria Bioscience Corp (LEXX) is $3.6711, with a high forecast of $7.3079 and a low forecast of $0.0342. This indicates an +5.19% increase from the last price of $3.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1227 | $0.1573 | $0.1327 | -96.49% |
| February, 2027 | $0.3989 | $0.0342 | $0.7389 | -88.57% |
| March, 2027 | $0.3968 | $0.2121 | $0.8337 | -88.63% |
| April, 2027 | $1.1869 | $0.2893 | $1.1869 | -65.99% |
| May, 2027 | $0.2512 | $0.1743 | $3.6894 | -92.80% |
| June, 2027 | $0.00139 | $0.178 | $1.4751 | -99.96% |
| July, 2027 | $0.1861 | $0.2423 | $0.4377 | -94.67% |
| August, 2027 | $0.6796 | $0.0696 | $3.3802 | -80.53% |
| September, 2027 | $1.6922 | $0.6328 | $2.1091 | -51.51% |
| October, 2027 | $1.3047 | $1.2347 | $2.1316 | -62.61% |
| November, 2027 | $0.7104 | $0.1904 | $7.3079 | -79.64% |
| December, 2027 | $1.163 | $0.5837 | $2.193 | -66.68% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2028
In 2028, Lexaria Bioscience Corp (LEXX) is projected to reach an average price of $1.1809, with a high projection of $2.2818 and a low estimate of $0.0799. This indicates an -66.16% fall from the last price of $3.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6787 | $0.9461 | $2.2293 | -51.90% |
| February, 2028 | $1.4812 | $1.2281 | $2.2818 | -57.56% |
| March, 2028 | $0.5938 | $0.3038 | $1.9444 | -82.99% |
| April, 2028 | $0.4236 | $0.0799 | $1.4501 | -87.86% |
| May, 2028 | $0.418 | $0.1111 | $0.4189 | -88.02% |
| June, 2028 | $0.5454 | $0.4948 | $0.47 | -84.37% |
| July, 2028 | $1.5097 | $0.9391 | $0.8128 | -56.74% |
| August, 2028 | $1.1621 | $0.9203 | $0.9471 | -66.70% |
| September, 2028 | $1.2546 | $1.164 | $1.0761 | -64.05% |
| October, 2028 | $1.8089 | $1.962 | $1.8783 | -48.17% |
| November, 2028 | $0.9163 | $0.9963 | $1.5426 | -73.74% |
| December, 2028 | $1.0038 | $1.0638 | $0.8371 | -71.24% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2029
The 2029 price forecast for Lexaria Bioscience Corp Stock (LEXX) is $0.9281 on average, with a high prediction of $1.847 and a low estimate of $0.00921. This represents an -73.41% decrease from the previous price of $3.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7881 | $0.9412 | $0.8496 | -77.42% |
| February, 2029 | $0.7605 | $0.6486 | $0.515 | -78.21% |
| March, 2029 | $1.393 | $1.1693 | $1.098 | -60.09% |
| April, 2029 | $1.0273 | $1.2873 | $1.2798 | -70.56% |
| May, 2029 | $0.3448 | $0.4147 | $0.9242 | -90.12% |
| June, 2029 | $0.7422 | $0.4215 | $0.6622 | -78.73% |
| July, 2029 | $0.1236 | $0.1141 | $0.4121 | -96.46% |
| August, 2029 | $0.00607 | $0.0239 | $0.2561 | -99.83% |
| September, 2029 | $0.3514 | $0.00921 | $0.6708 | -89.93% |
| October, 2029 | $0.5157 | $0.3751 | $0.4857 | -85.22% |
| November, 2029 | $1.9417 | $0.7024 | $1.7781 | -44.36% |
| December, 2029 | $1.8774 | $1.8706 | $1.847 | -46.21% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2030
Lexaria Bioscience Corp Stock (LEXX) is expected to reach an average price of $2.2724 in 2030, with a high forecast of $4.0953 and a low forecast of $0.4496. This signifies an -34.89% decrease from the last price of $3.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.6572 | $1.7298 | $1.7143 | -52.52% |
| February, 2030 | $1.4922 | $1.5923 | $1.5235 | -57.24% |
| March, 2030 | $1.2499 | $1.2829 | $1.3192 | -64.19% |
| April, 2030 | $1.1842 | $1.2766 | $1.2373 | -66.07% |
| May, 2030 | $0.9315 | $1.0115 | $1.1509 | -73.31% |
| June, 2030 | $0.6891 | $0.7152 | $0.6684 | -80.26% |
| July, 2030 | $0.6133 | $0.4496 | $0.5858 | -82.43% |
| August, 2030 | $1.4906 | $0.5801 | $4.0953 | -57.29% |
| September, 2030 | $2.157 | $1.9059 | $1.807 | -38.19% |
| October, 2030 | $2.7882 | $2.4623 | $2.7329 | -20.11% |
| November, 2030 | $3.1794 | $3.0235 | $2.8841 | -8.90% |
| December, 2030 | $1.1558 | $2.0558 | $1.8753 | -66.88% |
3.18%
Cap:
|
Volume (24h):